X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3187) 3187
Publication (184) 184
Magazine Article (124) 124
Newspaper Article (122) 122
Book Chapter (79) 79
Book Review (45) 45
Trade Publication Article (38) 38
Government Document (22) 22
Conference Proceeding (17) 17
Newsletter (16) 16
Book / eBook (13) 13
Dissertation (8) 8
Web Resource (8) 8
Data Set (3) 3
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1554) 1554
index medicus (1464) 1464
biosimilar (1013) 1013
biosimilars (979) 979
biosimilar pharmaceuticals (771) 771
biosimilar pharmaceuticals - therapeutic use (651) 651
pharmacology & pharmacy (623) 623
biological products (523) 523
safety (429) 429
oncology (379) 379
infliximab (374) 374
drug approval (336) 336
female (334) 334
pharmaceutical industry (334) 334
male (322) 322
double-blind (304) 304
united states (289) 289
efficacy (287) 287
immunogenicity (281) 281
biosimilar pharmaceuticals - adverse effects (280) 280
monoclonal antibodies (266) 266
animals (261) 261
adult (257) 257
treatment outcome (253) 253
laws, regulations and rules (238) 238
middle aged (238) 238
rheumatology (234) 234
analysis (225) 225
rheumatoid arthritis (222) 222
biosimilar pharmaceuticals - economics (217) 217
therapeutic equivalency (211) 211
drugs (205) 205
ct-p13 (199) 199
antibodies (196) 196
biologics (193) 193
biosimilar pharmaceuticals - administration & dosage (190) 190
medicine & public health (185) 185
biotechnology & applied microbiology (184) 184
generic drugs (179) 179
innovator infliximab (179) 179
clinical trials (177) 177
parallel-group (177) 177
pharmacokinetics (177) 177
antibodies, monoclonal - therapeutic use (176) 176
cancer (170) 170
patients (170) 170
research (166) 166
biotechnology (165) 165
europe (164) 164
medicine, research & experimental (163) 163
biosimilar pharmaceuticals - pharmacology (159) 159
chemotherapy (159) 159
proteins (157) 157
biosimilar pharmaceuticals - pharmacokinetics (155) 155
biosimilar pharmaceuticals - standards (154) 154
inflammatory bowel disease (154) 154
pharmacology (153) 153
filgrastim (152) 152
fda approval (151) 151
care and treatment (148) 148
usage (146) 146
biosimilar pharmaceuticals - chemistry (145) 145
aged (144) 144
immunology (144) 144
studies (141) 141
biopharmaceuticals (136) 136
arthritis (133) 133
medicine (133) 133
united states food and drug administration (130) 130
drug therapy (129) 129
rheumatoid-arthritis (129) 129
hematology (124) 124
medicine, general & internal (124) 124
review (123) 123
gastroenterology & hepatology (122) 122
interchangeability (121) 121
adalimumab (120) 120
etanercept (119) 119
therapy (119) 119
pharmacovigilance (118) 118
ulcerative colitis (118) 118
glycosylation (116) 116
psoriasis (113) 113
antirheumatic agents - therapeutic use (111) 111
young adult (111) 111
granulocyte colony-stimulating factor (107) 107
health aspects (107) 107
infliximab - therapeutic use (107) 107
arthritis, rheumatoid - drug therapy (106) 106
colony-stimulating factor (106) 106
crohns-disease (106) 106
comparability (105) 105
product development (105) 105
biological products - therapeutic use (103) 103
biochemical research methods (102) 102
manufacturing (101) 101
medical research (101) 101
crohn's disease (100) 100
internal medicine (100) 100
biomedicine (99) 99
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3276) 3276
German (66) 66
Spanish (54) 54
French (51) 51
Russian (45) 45
Polish (15) 15
Czech (13) 13
Korean (10) 10
Chinese (8) 8
Portuguese (8) 8
Italian (7) 7
Japanese (7) 7
Hungarian (5) 5
Slovak (5) 5
Slovenian (4) 4
Turkish (4) 4
Dutch (3) 3
Croatian (2) 2
Swedish (2) 2
Greek (1) 1
Icelandic (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arthritis Research and Therapy, ISSN 1478-6354, 01/2016, Volume 18, Issue 1, p. 25
Background: CT-P13 (Remsima (R), Inflectra (R)) is a biosimilar of the infliximab reference product (RP; Remicade (R)) and is approved in Europe and elsewhere,... 
Immunogenicity | Infliximab | Clinical trial | Efficacy | ASAS | Safety | CT-P13 | Pharmacokinetics | Ankylosing spondylitis | Biosimilar | MULTICENTER | INNOVATOR INFLIXIMAB | ACTIVE RHEUMATOID-ARTHRITIS | METHOTREXATE | MONOCLONAL-ANTIBODY | RHEUMATOLOGY | 2010 UPDATE | SPONDYLOARTHRITIS | RECOMMENDATIONS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Infliximab - therapeutic use | Infliximab - pharmacokinetics | Young Adult | Infliximab - adverse effects | Antirheumatic Agents - adverse effects | Biosimilar Pharmaceuticals - pharmacokinetics | Adult | Female | Neutropenia - chemically induced | Antirheumatic Agents - therapeutic use | Biosimilar Pharmaceuticals - therapeutic use | Double-Blind Method | Spondylitis, Ankylosing - drug therapy | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Spondylitis, Ankylosing - metabolism | Biosimilar Pharmaceuticals - adverse effects | Self Report - standards | Spondylitis, Ankylosing - diagnosis | Internationality | Adolescent | Antirheumatic Agents - pharmacokinetics | Aged | Chemical and Drug Induced Liver Injury | Longitudinal Studies | Complications and side effects | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Dosage and administration | Research | Drug therapy | Methods
Journal Article
Journal Article
Journal of Pharmaceutical Health Services Research, ISSN 1759-8885, 03/2019, Volume 10, Issue 1, pp. 3 - 4
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2018, Volume 36, Issue 12, pp. 1260 - 1265
Journal Article
La Revue du praticien, ISSN 0035-2640, 04/2018, Volume 68, Issue 4, p. 359
Journal Article
Journal Article